Are you in the process of embracing and embedding an omnichannel approach within your organization?
As with many sectors, the Covid-19 pandemic has exponentially accelerated digital transformation within BioPharma. The industry has responded by working extremely hard to speed up it’s evolution of digital processes and approaches. The hope was that they would soon be as advanced as the science that is at the core of their businesses.
But, for many, the journey has only really just begun, with omnichannel orchestration, a.k.a. hybrid approaches or rep orchestration being a common critical starting point.
Whether you are moving towards a purely digital, solely remote engagement or rep orchestrated working, blending the old with the new is a particularly difficult journey to navigate.
Whilst the concepts are arguably relatively simple, (after all look at the wonders that the likes of Amazon or Netflix have achieved in the way they predict, understand and engage with us as their customers), picking this up and applying it to Biopharma is a somewhat more complex experience.
However you define your customers; patients and healthcare professionals alike are all consumers in their own right. Omnichannel orchestration has become a key step towards achieving better quality methodologies and accessibility of information.
In a recent poll developed by Attensi, based on insights from our existing clients on this subject, we asked BioPharma representatives via LinkedIn to highlight their key challenges when it came to achieving the panacea known as “Customer Centricity”:
The biggest challenge identified was implementation effectiveness.
Respondents replied that they may well have selected more options, if not all of them if they could.
What is abundantly clear though, is that all parts of a pharmaceutical organisation need be moving in the same direction and travelling this journey together.
Never has there been such an important time to embed truly cross-functional working.